GlobeNews Wire

IMAAVY (nipocalimab)shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)

Through 120 weeks of follow-up, nipocalimab delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including…

2 weeks ago

Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting

April 23, 2026 12:00 ET  | Source: Catheter Precision, Inc. VIVO System to be featured in educational sessions at HRS…

2 weeks ago

GigaCloud Technology Inc Announces Planned Retirement of Head of Brand Center

April 22, 2026 17:00 ET  | Source: GigaCloud Technology EL MONTE, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology…

2 weeks ago

BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-K Filing

HOLMDEL, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management…

2 weeks ago

Alzai Health Corp. Files Final Prospectus in Connection With Initial Public Offering

April 22, 2026 16:17 ET  | Source: Alzai Health Corp. Not for distribution to U.S. Newswire services or for dissemination…

2 weeks ago

SkinHealth Systems Inc. Appoints Three New Independent Directors to Board

Kenneth Tripp, Dr. Sachin Shridharani, and E. Scott Beattie bring deep expertise in medical devices, aesthetic medicine, and global consumer…

2 weeks ago

TOMI Environmental Solutions Scales Automation with SteraMist iHP Robot Upgrade; Targets Fast Growing Robotaxi Market

Pairing Decontamination Versatility with Domestic Lithium Power to Meet the Global Demand for High-Performance Automated Disinfection April 22, 2026 16:05…

2 weeks ago

Abivax to Present Data on Obefazimod at Digestive Disease Week

Abivax to Present Data on Obefazimod at Digestive Disease Week® Presentations Highlight Comprehensive Efficacy, Safety, and Patient-Reported Outcomes from the…

2 weeks ago

Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies…

2 weeks ago

RNK Health NAD+ Longevity Therapy Claims Evaluated: The Clinician-Guided NAD Injections & Medication Protocol

Des Moines, IA, April 21, 2026 (GLOBE NEWSWIRE) -- The information below contains affiliate links. If a purchase is made…

2 weeks ago